|
Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid
Stephen B. Soumerai
States are reacting to increased Medicaid drug costs by implementing cost-control policies, such as preferred drug lists (PDLs) and prior authorization. PDLs have risks as well as benefits. Targeting essential drug classes with heterogeneous patient responses and side effects could reduce appropriate care, adversely affect health status, and cause shifts to more costly types of care. Assessing inappropriate use of high-cost drugs before implementing regulations and instituting simple mechanisms to exempt high-risk patients could maximize savings and minimize harm. The current exponential growth in such policies and the limited evidence base justifies investment in research to identify which policies can achieve savings without unintended consequences.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
E. E. Roughead, J. D. Barratt, E. Ramsay, N. Pratt, P. Ryan, R. Peck, G. Killer, and A. L. Gilbert
The Effectiveness of Collaborative Medicine Reviews in Delaying Time to Next Hospitalization for Patients With Heart Failure in the Practice Setting: Results of a Cohort Study
Circ Heart Fail,
September 1, 2009;
2(5):
424 - 428.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Thanassoulis, I. Karp, K. Humphries, J. V. Tu, M. J. Eisenberg, and L. Pilote
Impact of Restrictive Prescription Plans on Heart Failure Medication Use
Circ Cardiovasc Qual Outcomes,
September 1, 2009;
2(5):
484 - 490.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Majumdar and S. B. Soumerai
The Unhealthy State Of Health Policy Research
Health Aff.,
September 1, 2009;
28(5):
w900 - w908.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. West, J. E. Wilk, D. S. Rae, I. S. Muszynski, M. R. Stipec, C. L. Alter, K. E. Sanders, S. Crystal, and D. A. Regier
Medicaid Prescription Drug Policies and Medication Access and Continuity: Findings From Ten States
Psychiatr Serv,
May 1, 2009;
60(5):
601 - 610.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Meagher, A. Pullela, M. Meisinger, N. Geaney, and S. O'Brien
Five-year follow-up of an evidence-based prescribing intervention
The Psychiatrist,
May 1, 2008;
32(5):
183 - 186.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Soumerai, F. Zhang, D. Ross-Degnan, D. E. Ball, R. F. LeCates, M. R. Law, T. E. Hughes, D. Chapman, and A. S. Adams
Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change
Health Aff.,
May 1, 2008;
27(3):
w185 - w195.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang and S. B. Soumerai
Do Newer Prescription Drugs Pay For Themselves? A Reassessment Of The Evidence
Health Aff.,
May 1, 2007;
26(3):
880 - 886.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Califf, R. A. Harrington, L. K. Madre, E. D. Peterson, D. Roth, and K. A. Schulman
Curbing The Cardiovascular Disease Epidemic: Aligning Industry, Government, Payers, And Academics
Health Aff.,
January 1, 2007;
26(1):
62 - 74.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Hartung, K. L. Ketchum, and D. G. Haxby
An Evaluation Of Oregon's Evidence-Based Practitioner-Managed Prescription Drug Plan
Health Aff.,
September 1, 2006;
25(5):
1423 - 1432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. E. McElwee, S. Y. Ho, K. A. McGuigan, and M. L. Horn
Evidence-Based Coverage Decisions? Primum Non Nocere
Health Aff.,
July 1, 2006;
25(4):
W279 - W282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Elliott, S. R. Majumdar, M. R. Gillick, and S. B. Soumerai
Benefits and Consequences for the Poor and the Disabled
N. Engl. J. Med.,
December 29, 2005;
353(26):
2739 - 2741.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Z. Bambauer, J. E. Sabin, and S. B. Soumerai
The Exclusion of Benzodiazepine Coverage in Medicare: Simple Steps for Avoiding a Public Health Crisis
Psychiatr Serv,
September 1, 2005;
56(9):
1143 - 1146.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. PARK, D. ROSS-DEGNAN, A. S. ADAMS, J. SABIN, P. KANAVOS, and S. B. SOUMERAI
Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: Population-based study
The British Journal of Psychiatry,
August 1, 2005;
187(2):
137 - 142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. E. Morden and S. D. Sullivan
States' Control Of Prescription Drug Spending: A Heterogeneous Approach
Health Aff.,
July 1, 2005;
24(4):
1032 - 1038.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Briesacher, M. R. Limcangco, L. Simoni-Wastila, J. A. Doshi, S. R. Levens, D. G. Shea, and B. Stuart
The Quality of Antipsychotic Drug Prescribing in Nursing Homes
Arch Intern Med,
June 13, 2005;
165(11):
1280 - 1285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Koyanagi, S. Forquer, and E. Alfano
Medicaid Policies To Contain Psychiatric Drug Costs
Health Aff.,
March 1, 2005;
24(2):
536 - 544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. K. Choudhry and A. S. Detsky
A Perspective on US Drug Reimportation
JAMA,
January 19, 2005;
293(3):
358 - 362.
[Full Text]
[PDF]
|
|
|
|
